Welcome to our dedicated page for SCOTTS MIRACLE-GRO CO SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCOTTS MIRACLE-GRO CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCOTTS MIRACLE-GRO CO's regulatory disclosures and financial reporting.
The Scotts Miracle-Gro Company (SMG) reported execution of key capital allocation steps, including redeeming all $250 million of its 5.250% Senior Notes due 2026 on September 11, 2026, at principal plus accrued interest. The redemption was funded with a combination of available revolver debt and planned Fiscal 2026 excess free cash flow.
The company renewed its $750 million accounts receivable facility with JPMorgan Chase Bank, N.A., extending maturity to August 31, 2027, and began its Board-authorized $500 million share repurchase program with $25 million of repurchases in August. Scotts Miracle-Gro achieved its $275 million free cash flow target, reaffirmed Fiscal 2026 guidance including non-GAAP adjusted gross margin of at least 32%, non-GAAP adjusted EPS from continuing operations of $4.30–$4.45, mid single-digit non-GAAP adjusted EBITDA growth, and a leverage ratio expected to decline to the high 3s.
SCOTTS MIRACLE-GRO CO (SMG) reports a board change: on September 8, 2026, director Adam Hanft notified the company of his retirement from the Board of Directors, effective immediately. Hanft had been serving as a Class III director with a term scheduled to run until the company’s 2028 Annual Meeting of Shareholders.
The company states that its consulting relationship with Hanft Ideas LLC, where Adam Hanft is principal and Chief Executive Officer, will continue following his retirement from the Board, maintaining an advisory connection with him outside of his former director role.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Evans David C reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director David C. Evans received an award of 118 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU grants and are the economic equivalent of common shares. Following this award, Evans holds 791 Dividend Equivalent Rights directly. No Rule 10b5-1 trading plan is reported.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Aviles Edith reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director Edith Aviles received a grant of 118 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU grants and are each economically equivalent to one common share, bringing her reported derivative holdings to 791 rights.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Candelino Roberto reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director Roberto Candelino received a grant of 77 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU awards and are economically equivalent to 77 common shares, bringing his directly held Dividend Equivalent Rights to 374.
SCOTTS MIRACLE-GRO CO (SMG) director Austin Scott Miller reported an acquisition of 53 Dividend Equivalent Rights on September 4, 2026. These rights are tied to existing DSU or RSU grants and are economically equivalent to common shares, bringing his directly held Dividend Equivalent Rights balance to 189.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. HAGEDORN KATHERINE LITTLEFIELD reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director and ten percent owner Katherine Littlefield Hagedorn received a grant of 37 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU awards and are economically equivalent to 37 common shares of the company, bringing her reported Dividend Equivalent Rights holdings to 108.
SCOTTS MIRACLE-GRO CO (SMG) director, President and CEO Nathan Eric Baxter reported a Form 4 transaction involving common shares. On September 5, 2026, 12,023 common shares were delivered or withheld at $57.53 per share to pay an option exercise price or tax liability, leaving 78,442.5948 common shares held directly. He also reports an indirect holding representing a proportionate interest in 36,993 common shares through Hagedorn Partnership, L.P., in which he is a general partner and in which certain family members also hold interests. No Rule 10b5-1 trading plan is indicated.
SCOTTS MIRACLE-GRO CO (SMG) director Peter E. Shumlin reported an acquisition of 170 Dividend Equivalent Rights on September 4, 2026, as a grant or award linked to existing DSU or RSU grants. Each right is the economic equivalent of one common share of the issuer, bringing his directly held Dividend Equivalent Rights to 1,188.
SCOTTS MIRACLE-GRO CO (SMG) director Stephen L. Johnson reported an acquisition of 155 dividend equivalent rights on September 4, 2026. These derivative rights are tied to DSU or RSU grants and bring his directly held dividend equivalent rights to 1,063, each economically equivalent to one common share.